McClellan S - Search Results

1

High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.

McClellan S, Jiang X, Barrett R, Hazlett LD. McClellan S, et al. J Immunol. 2015 Feb 15;194(4):1776-87. doi: 10.4049/jimmunol.1401684. Epub 2015 Jan 14. J Immunol. 2015. PMID: 25589066 Free PMC article.

2

Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.

Hazlett LD, McClellan S, Kwon B, Barrett R. Hazlett LD, et al. Among authors: mcclellan s. Invest Ophthalmol Vis Sci. 2000 Mar;41(3):805-10. Invest Ophthalmol Vis Sci. 2000. PMID: 10711697

3

Aging and PMN response to P. aeruginosa infection.

Kernacki KA, Barrett RP, McClellan SA, Hazlett LD. Kernacki KA, et al. Among authors: mcclellan sa. Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3019-25. Invest Ophthalmol Vis Sci. 2000. PMID: 10967059

4

B7/CD28 costimulation is critical in susceptibility to Pseudomonas aeruginosa corneal infection: a comparative study using monoclonal antibody blockade and CD28-deficient mice.

Hazlett LD, McClellan S, Barrett R, Rudner X. Hazlett LD, et al. Among authors: mcclellan s. J Immunol. 2001 Jan 15;166(2):1292-9. doi: 10.4049/jimmunol.166.2.1292. J Immunol. 2001. PMID: 11145712

5

MIP-1alpha regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection.

Kernacki KA, Barrett RP, McClellan S, Hazlett LD. Kernacki KA, et al. Among authors: mcclellan s. J Leukoc Biol. 2001 Dec;70(6):911-9. J Leukoc Biol. 2001. PMID: 11739554

6

The role of Langerhans cells in Pseudomonas aeruginosa infection.

Hazlett LD, McClellan SA, Rudner XL, Barrett RP. Hazlett LD, et al. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):189-97. Invest Ophthalmol Vis Sci. 2002. PMID: 11773031

7

Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.

Hazlett LD, Rudner XL, McClellan SA, Barrett RP, Lighvani S. Hazlett LD, et al. Among authors: mcclellan sa. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):419-24. Invest Ophthalmol Vis Sci. 2002. PMID: 11818386

8

IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-gamma production.

Huang X, McClellan SA, Barrett RP, Hazlett LD. Huang X, et al. J Immunol. 2002 Jun 1;168(11):5756-63. doi: 10.4049/jimmunol.168.11.5756. J Immunol. 2002. PMID: 12023376

9

Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.

McClellan SA, Huang X, Barrett RP, van Rooijen N, Hazlett LD. McClellan SA, et al. J Immunol. 2003 May 15;170(10):5219-27. doi: 10.4049/jimmunol.170.10.5219. J Immunol. 2003. PMID: 12734370

10

Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.

Hazlett LD, Huang X, McClellan SA, Barrett RP. Hazlett LD, et al. Among authors: mcclellan sa. Eye (Lond). 2003 Nov;17(8):863-71. doi: 10.1038/sj.eye.6700558. Eye (Lond). 2003. PMID: 14631390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters